Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
04/2003
04/16/2003EP0824544B1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
04/16/2003CN1411446A Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors
04/16/2003CN1410835A Organic photoreceptor for electronic photographing
04/16/2003CN1410834A Organic light receptor with charge transfer compound for electronic photographing
04/16/2003CN1105723C Spirocyclic metalloprotease inhibitors
04/16/2003CN1105705C Process for preparing heterocyclic amide derivative with specific physical status
04/15/2003US6548547 Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators
04/15/2003US6548532 Topically applying onto the afflicted skin and/or scalp cosmetically/ therapeutically effective amount of indolecarboxylic acid compound, or ester or salt thereof
04/15/2003US6548530 Antitumor drugs incorporate the 1,2,9,9a-tetrahydrocyclopropa(c)benz(e)indol-4-one (CBI) alkylation subunit; cytotoxic activity
04/15/2003US6548526 Isothiazole derivatives useful as anticancer agents
04/15/2003US6548502 Preventing disorder selected from pathological gambling, attention deficit disorder with hyperactivity disorder, substance addiction such as drug and alcohol and sex in a mammals by administering pyrido(1,2-a) pyrazine derivatives
04/15/2003CA2172854C Antimicrobial indole derivatives
04/15/2003CA2099588C Prevention of synovial adhesions
04/10/2003WO2003029226A1 Heterocyclyl substituted phenoxyalkyl-, phenylthioalkyl-, phenylaminoalkyl- and phenylalkyl-sulfamoylcarboxamides
04/10/2003WO2003029214A1 Pseudopolymorphic forms of carvedilol
04/10/2003WO2003029213A1 Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones
04/10/2003WO2003029212A1 Indole derivatives as cox ii inhibitors
04/10/2003WO2003029211A1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor
04/10/2003WO2003029199A1 Benzene derivatives, process for preparing the same and use thereof
04/10/2003WO2003028728A1 4-(4-substituted piperazinyl-1yl)-butylcarboxamides as d3 dopamine subtype selective ligands
04/10/2003WO2003028719A1 Substituted 2,5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases
04/10/2003WO2003028650A2 Benzimidazolidinone derivatives as muscarinic agents
04/10/2003WO2003007069A3 Novel nonlinear optical polymers
04/10/2003WO2002071827A3 Retinoid x receptor modulators
04/10/2003WO2002041889A3 Indolsulfonyl compounds useful in the treatment of cns disorders
04/10/2003WO2002018321A3 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
04/10/2003US20030069431 Method for synthesis of perindopril and its pharmaceutically acceptable salts
04/10/2003US20030069430 Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects
04/10/2003US20030069416 Cycloalkylpyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivatives
04/10/2003US20030069312 Nitromethyl ketones, process for preparing them and compositions containing them
04/10/2003US20030069299 Substituted indolinones, preparation thereof and their use as pharmaceutical compositions
04/10/2003US20030069297 4-aryl substituted indolinones
04/10/2003US20030069267 Modulators of protein tyrosine phosphatases (PTPases)
04/10/2003US20030069249 Analgesics; central nervous system disorders
04/10/2003US20030069245 Aids therapy
04/10/2003US20030069233 Central nervous system disorders; psychological disorders; Alzheimer's disease
04/10/2003US20030069225 Synthesis of taxol enhancers
04/10/2003US20030069222 Used as anti-viral agents against the HIV-1 and HIV-2 viruses.
04/10/2003CA2461919A1 Substituted 2,5-diamidoindoles as ece inhibitors for the treatment of cardiovascular diseases
04/10/2003CA2461670A1 Indole derivatives as cox ii inhibitors
04/10/2003CA2460486A1 Pseudopolymorphic forms of carvedilol
04/10/2003CA2457647A1 Benzimidazolidinone derivatives as muscarinic agents
04/09/2003EP1299774A1 Perfluoroalkylsulfonic acid compounds for photoresists
04/09/2003EP1299722A1 Methods for encoding combinatorial libraries
04/09/2003EP1299401A1 Chiral ligands for asymmetric catalysis
04/09/2003EP1299382A1 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
04/09/2003EP1299355A2 (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors
04/09/2003EP1299101A1 Carvedilol
04/09/2003EP1198453B1 N-(indolcarbonyl-)piperazin derivatives
04/09/2003EP0993458B1 3-benzylpiperidine
04/09/2003EP0850224B1 Radiation-activated cytotoxin therapy
04/09/2003EP0792257B1 Material for dichroic light polarizers
04/09/2003CN1409729A Substituted group-4 metal complexes, catalysts and olefin polymerization process
04/09/2003CN1105103C Amino-iminoisoindolenine benzene sulfonate, and process for preparation of nitrate and benzene sulfonate salts of amino-aminoiso indolenine derivatives
04/08/2003US6545161 Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
04/08/2003US6545158 Such as N-(3,5-dichloropyridin-4-yl)-2-(1-(4-fluorobenzyl)-5-hydroxyindol-3-yl)-2 -oxoacetamide; for treatment of eosinophil-related disorders and chronic obstructive pulmonary disease
04/08/2003US6545108 Catalysts containing N-pyrrolyl substituted nitrogen donors
04/08/2003US6545053 Aminoethoxyfluorene derivatives are beta-3 adrenaline receptor agonists and are useful as drugs for the treatment and prevention of diabetes, obesity, hyperlipemia, etc.
04/08/2003US6545051 Antibacterial hydroxamic acid derivatives
04/08/2003US6545036 Potassium channel blockers; neuroprotectants, glaucoma, n-benzoyl indole compounds with 3-acylureamethyl group
04/08/2003US6545035 Substituted indolinones with kinase inhibitory activity
04/08/2003US6545025 Antiinflammatroy agents; antiallergens
04/08/2003US6545018 Oxamic acids and derivatives as thyroid receptor ligands
04/08/2003US6544987 Compounds, compositions, and methods for stimulating neuronal growth and elongation
04/08/2003US6544970 Administering in a first phase of a progestational agent (levonorgestrel or ethinylestradiol) and in a second phase an antiprogestin that is an indolinone derivative, especially a 3-spiroalkylene derivative
04/08/2003US6544951 Antiinflammatory agents; autoimmune diseases, nervous system degradation
04/08/2003CA2123548C Piperazine derivatives
04/08/2003CA2049212C 6-substituted-tetrahydrobenz ¬cd| indoles
04/03/2003WO2003027314A2 Protected linker compounds
04/03/2003WO2003027275A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
04/03/2003WO2003027102A1 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors
04/03/2003WO2003027089A1 Benzofuran, indole or benzothiophene 2,4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors
04/03/2003WO2003027071A1 Method for preparing n-($g(v)-bromoalkyl)phthalimides
04/03/2003WO2003027070A1 Method for preparing n-($g(v)-bromoalkyl)phthalimides
04/03/2003WO2003027068A2 Substituted amines for the treatment of neurological disorders
04/03/2003WO2003027059A1 Acid amide derivatives, process for producing these, and pest control agent containing these
04/03/2003WO2002086078A3 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents
04/03/2003US20030065219 Cyclization of an alcohol containing urea compound
04/03/2003US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
04/03/2003US20030065146 Compound for use in the treatment of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease and sepsis
04/03/2003US20030065031 Glucagon antagonists/inverse agonists
04/03/2003US20030065023 Anticancer agents, viricides, psychological disorders
04/03/2003US20030065007 Analgesics; psychological disorders; antidepressants
04/03/2003US20030064995 Antidepressants, anxiolytic agents
04/03/2003US20030064991 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
04/03/2003US20030064977 Viricides
04/03/2003US20030064246 Blue light emitting compound and organic electroluminescent device employing the same as color developing substance
04/03/2003US20030063365 Electrochromic solution containing hydrazone compound and device manufactured with same
04/03/2003CA2461603A1 Substituted amines for the treatment of neurological disorders
04/03/2003CA2460000A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
04/02/2003EP1298496A2 Electrophotographic organophotoreceptors
04/02/2003EP1297833A1 Indole carboxylic acids as thyroid receptor ligands
04/02/2003EP1297175A2 Methods and compounds for modulating nuclear receptor coactivator binding
04/02/2003EP1296954A1 Bicyclic lactams and sulfonamides with 5-ht1a-affinity and use thereof for preventing and treating cerebral ischaemia
04/02/2003EP1296948A2 Novel gamma crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same.
04/02/2003EP1296947A1 $g(A) CRYSTALLINE FORM OF PERINDOPRIL TERT-BUTYLAMINE SALT
04/02/2003EP1296943A1 Amino acid derivatives and their use as medicines
04/02/2003EP1296942A1 Glucagon antagonists/inverse agonists
04/02/2003EP1296938A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
04/02/2003EP1296936A1 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones